HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Picks Outsider With Broad Experience To Lead Consumer Group

This article was originally published in The Tan Sheet

Executive Summary

Bayer CropScience CEO Sandra Peterson will join Johnson & Johnson Dec. 1 as group worldwide chairman with oversight of consumer companies, IT and global supply chain. Worldwide Consumer Group Chairman Jesse Wu will report to Peterson, who also takes a seat on J&J’s executive committee.

You may also be interested in...



J&J’s Gorsky Promises Prioritization Of OTC Business

Johnson & Johnson’s Q2 was another quarter of flat consumer products growth, with the return of some OTCs to market delayed until 2013. In his quarterly earnings call debut, CEO Alex Gorsky emphasized the firm’s commitment to diversification and restoring the supply of OTC products.

J&J’s Path Forward – An Interview With Alex Gorsky

In a conversation shortly before taking the helm at Johnson & Johnson, CEO Gorsky discusses deal strategies, emerging markets, his experience overseeing both the device and pharma businesses and the value of J&J’s consumer health product portfolio.

McCoy Exits J&J For Avon After Gorsky Promotion

Passed over to succeed outgoing CEO William Weldon, top Johnson & Johnson consumer business exec Sheri McCoy exits the firm after 30 years to become Avon’s CEO. While J&J’s consumer business is recovering gradually, Avon faces a hostile takeover bid and is dealing with internal struggles.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124953

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel